Omeros

Omeros is a Seattle-based commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of small-molecule and protein therapeutics for large markets as well as orphan indications targeting inflammation, complement-mediated diseases, and disorders of the central nervous system.